Failure of the mature hemodialysis arteriovenous fistula
- Gerald A Beathard, MD, PhD
Gerald A Beathard, MD, PhD
- Clinical Professor
- University of Texas Medical Branch
- Section Editors
- Jeffrey S Berns, MD
Jeffrey S Berns, MD
- Editor-in-Chief — Nephrology
- Section Editor — Dialysis
- Professor of Medicine
- Perelman School of Medicine at the University of Pennsylvania
- Joseph L Mills, Sr, MD
Joseph L Mills, Sr, MD
- Section Editor — Vascular and Endovascular Surgery
- Professor and Chief
- Division of Vascular Surgery and Endovascular Therapy
- Baylor College of Medicine
- John F Eidt, MD
John F Eidt, MD
- Section Editor — Vascular and Endovascular Surgery
- Professor of Surgery, Texas A&M Health Sciences Center - Dallas Campus
- Vice Chair of Vascular Surgical Services, Baylor Heart and Vascular Hospital at Dallas
Late failure of a hemodialysis arteriovenous fistula (AVF) is defined as the inability to use a matured AVF after at least three months of normal usage. Although the mature hemodialysis arteriovenous fistula is associated with fewer complications compared with other types of vascular access, when problems occur, they need to be managed effectively. The main causes of failure in a mature hemodialysis arteriovenous fistula are vascular stenotic lesions. These lesions manifest as decreased flow leading to inadequate dialysis and eventually thrombosis.
Failure of the mature AVF and management will be reviewed here. Primary failure of the newly created hemodialysis arteriovenous fistula is reviewed separately as are other types of AVF dysfunction, such as hemodialysis ischemic syndrome, aneurysm formation, infection, and excess flow leading to congestive heart failure are discussed separately. (See "Primary failure of the hemodialysis arteriovenous fistula" and "Nonthrombotic complications of arteriovenous hemodialysis access".)
The risk factors associated with failure of a hemodialysis arteriovenous fistula are reviewed separately. In addition, it is not surprising that AVFs requiring intervention prior to maturation are more likely to fail in the long term, even if they appear to mature and are functional following intervention . (See "Creating an arteriovenous fistula for hemodialysis", section on 'Risk factors for AVF failure' and "Primary failure of the hemodialysis arteriovenous fistula", section on 'Fistula salvage'.)
MONITORING THE MATURE AVF
Failure of the mature hemodialysis arteriovenous fistula (AVF) is frequently suspected during monitoring designed to detect stenosis so that it can be identified and treated prior to thrombosis, usually on the basis of physical examination findings, flow measurements, or duplex ultrasound [2,3]. Lesions associated with the mature hemodialysis arteriovenous fistulas can include arterial or venous stenosis (preexisting or acquired), and collateral veins. These are described in more detail elsewhere. (See "Primary failure of the hemodialysis arteriovenous fistula", section on 'Associated lesions'.)
Findings on physical examination associated with vascular stenotic lesions or thrombosis are listed briefly below, and these, along with other methods for monitoring and surveillance of fistulas, are discussed in detail elsewhere. (See "Examination of the mature hemodialysis arteriovenous fistula" and "Clinical monitoring and surveillance of the mature hemodialysis arteriovenous fistula".)
- Lee T, Ullah A, Allon M, et al. Decreased cumulative access survival in arteriovenous fistulas requiring interventions to promote maturation. Clin J Am Soc Nephrol 2011; 6:575.
- Vascular Access Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006; 48 Suppl 1:S248.
- Hemodialysis Adequacy 2006 Work Group. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 2006; 48 Suppl 1:S2.
- NKF-K/DOQI Clinical Practice Guidelines For Vascular Access. Clinical Practice Guideline 4: Detection of access dysfunction: monitoring, surveillance, and diagnostic testing. Am J Kidney Dis 2006; 48(Suppl 1):S248.
- Ethier JH, Lindsay RM, Barre PE, et al. Clinical practice guidelines for vascular access. Canadian Society pf Nephrology. J Am Soc Nephrol 1999; 10 Suppl 13:S297.
- NKF-K/DOQI Clinical Practice Guidelines For Vascular Access. Clinical Practice Guideline 5: Treatment of fistula complications. Am J Kidney Dis 2006; 48(Suppl 1):S248.
- Beathard GA. Angioplasty for arteriovenous grafts and fistulae. Semin Nephrol 2002; 22:202.
- Beathard GA, Settle SM, Shields MW. Salvage of the nonfunctioning arteriovenous fistula. Am J Kidney Dis 1999; 33:910.
- Falk A, Teodorescu V, Lou WY, et al. Treatment of "swing point stenoses" in hemodialysis arteriovenous fistulae. Clin Nephrol 2003; 60:35.
- Badero OJ, Salifu MO, Wasse H, Work J. Frequency of swing-segment stenosis in referred dialysis patients with angiographically documented lesions. Am J Kidney Dis 2008; 51:93.
- Rajan DK, Clark TW, Patel NK, et al. Prevalence and treatment of cephalic arch stenosis in dysfunctional autogenous hemodialysis fistulas. J Vasc Interv Radiol 2003; 14:567.
- Jaberi A, Schwartz D, Marticorena R, et al. Risk factors for the development of cephalic arch stenosis. J Vasc Access 2007; 8:287.
- Hammes M, Funaki B, Coe FL. Cephalic arch stenosis in patients with fistula access for hemodialysis: relationship to diabetes and thrombosis. Hemodial Int 2008; 12:85.
- Manninen HI, Kaukanen E, Mäkinen K, Karhapää P. Endovascular salvage of nonmaturing autogenous hemodialysis fistulas: comparison with endovascular therapy of failing mature fistulas. J Vasc Interv Radiol 2008; 19:870.
- Kian K, Unger SW, Mishler R, et al. Role of surgical intervention for cephalic arch stenosis in the "fistula first" era. Semin Dial 2008; 21:93.
- Kian K, Asif A. Cephalic arch stenosis. Semin Dial 2008; 21:78.
- Turmel-Rodrigues L, Pengloan J, Baudin S, et al. Treatment of stenosis and thrombosis in haemodialysis fistulas and grafts by interventional radiology. Nephrol Dial Transplant 2000; 15:2029.
- Clark TW, Hirsch DA, Jindal KJ, et al. Outcome and prognostic factors of restenosis after percutaneous treatment of native hemodialysis fistulas. J Vasc Interv Radiol 2002; 13:51.
- Duijm LE, Liem YS, van der Rijt RH, et al. Inflow stenoses in dysfunctional hemodialysis access fistulae and grafts. Am J Kidney Dis 2006; 48:98.
- Asif A, Gadalean FN, Merrill D, et al. Inflow stenosis in arteriovenous fistulas and grafts: a multicenter, prospective study. Kidney Int 2005; 67:1986.
- Romero A, Polo JR, Garcia Morato E, et al. Salvage of angioaccess after late thrombosis of radiocephalic fistulas for hemodialysis. Int Surg 1986; 71:122.
- Beathard, G. Complications of vascular access. In: Complications of Dialysis – Recognition and Management., Lameire, N, Mehta, R (Eds), Marcel Dekker, Inc, New York 2000. p. 1.
- Chang CJ, Ko YS, Ko PJ, et al. Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity. Kidney Int 2005; 68:1312.
- Ahmad I. Salvage of arteriovenous fistula by angioplasty of collateral veins establishing a new channel. J Vasc Access 2007; 8:123.
- Schilling JJ, Eiser AR, Slifkin RF, et al. The role of thrombolysis in hemodialysis access occlusion. Am J Kidney Dis 1987; 10:92.
- Beathard GA. Mechanical versus pharmacomechanical thrombolysis for the treatment of thrombosed dialysis access grafts. Kidney Int 1994; 45:1401.
- Trerotola SO, Johnson MS, Shah H, et al. Incidence and management of arterial emboli from hemodialysis graft surgical thrombectomy. J Vasc Interv Radiol 1997; 8:557.
- Kinney TB, Valji K, Rose SC, et al. Pulmonary embolism from pulse-spray pharmacomechanical thrombolysis of clotted hemodialysis grafts: urokinase versus heparinized saline. J Vasc Interv Radiol 2000; 11:1143.
- Bentaarit B, Duval AM, Maraval A, et al. Paradoxical embolism following thromboaspiration of an arteriovenous fistula thrombosis: a case report. J Med Case Rep 2010; 4:345.
- Haage P, Vorwerk D, Wildberger JE, et al. Percutaneous treatment of thrombosed primary arteriovenous hemodialysis access fistulae. Kidney Int 2000; 57:1169.
- Schon D, Mishler R. Salvage of occluded autologous arteriovenous fistulae. Am J Kidney Dis 2000; 36:804.
- Schon D, Mishler R. Pharmacomechanical thrombolysis of natural vein fistulas: reduced dose of TPA and long-term follow-up. Semin Dial 2003; 16:272.
- Turmel-Rodrigues L, Pengloan J, Rodrigue H, et al. Treatment of failed native arteriovenous fistulae for hemodialysis by interventional radiology. Kidney Int 2000; 57:1124.
- Beathard GA, Litchfield T, Physician Operators Forum of RMS Lifeline, Inc. Effectiveness and safety of dialysis vascular access procedures performed by interventional nephrologists. Kidney Int 2004; 66:1622.
- Huang HL, Chen CC, Chang SH, et al. Combination of duplex ultrasound-guided manual declotting and percutaneous transluminal angioplasty in thrombosed native dialysis fistulas. Ren Fail 2005; 27:713.
- Shatsky JB, Berns JS, Clark TW, et al. Single-center experience with the Arrow-Trerotola Percutaneous Thrombectomy Device in the management of thrombosed native dialysis fistulas. J Vasc Interv Radiol 2005; 16:1605.
- Beathard GA, Welch BR, Maidment HJ. Mechanical thrombolysis for the treatment of thrombosed hemodialysis access grafts. Radiology 1996; 200:711.
- Palmer RM, Cull DL, Kalbaugh C, et al. Is surgical thrombectomy to salvage failed autogenous arteriovenous fistulae worthwhile? Am Surg 2006; 72:1231.
- Ponikvar R. Surgical salvage of thrombosed arteriovenous fistulas and grafts. Ther Apher Dial 2005; 9:245.
- Lipari G, Tessitore N, Poli A, et al. Outcomes of surgical revision of stenosed and thrombosed forearm arteriovenous fistulae for haemodialysis. Nephrol Dial Transplant 2007; 22:2605.
- Moncef G. Surgical revision of failing or thrombosed native arteriovenous fistulas: a single center experience. Saudi J Kidney Dis Transpl 2010; 21:258.
- Falk A. Maintenance and salvage of arteriovenous fistulas. J Vasc Interv Radiol 2006; 17:807.
- Poulain F, Raynaud A, Bourquelot P, et al. Local thrombolysis and thromboaspiration in the treatment of acutely thrombosed arteriovenous hemodialysis fistulas. Cardiovasc Intervent Radiol 1991; 14:98.
- Jain G, Maya ID, Allon M. Outcomes of percutaneous mechanical thrombectomy of arteriovenous fistulas in hemodialysis patients. Semin Dial 2008; 21:581.
- Dixon BS, Novak L, Fangman J. Hemodialysis vascular access survival: upper-arm native arteriovenous fistula. Am J Kidney Dis 2002; 39:92.
- Añel RL, Yevzlin AS, Ivanovich P. Vascular access and patient outcomes in hemodialysis: questions answered in recent literature. Artif Organs 2003; 27:237.
- Huber TS, Carter JW, Carter RL, Seeger JM. Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J Vasc Surg 2003; 38:1005.
- Pisoni RL. Vascular access use and outcomes: results from the DOPPS. Contrib Nephrol 2002; :13.
- Pisoni RL, Young EW, Dykstra DM, et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 2002; 61:305.
- Ethier J, Mendelssohn DC, Elder SJ, et al. Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 2008; 23:3219.
- Tordoir JH, Rooyens P, Dammers R, et al. Prospective evaluation of failure modes in autogenous radiocephalic wrist access for haemodialysis. Nephrol Dial Transplant 2003; 18:378.
- Turmel-Rodrigues L, Mouton A, Birmelé B, et al. Salvage of immature forearm fistulas for haemodialysis by interventional radiology. Nephrol Dial Transplant 2001; 16:2365.
- Maya ID, O'Neal JC, Young CJ, et al. Outcomes of brachiocephalic fistulas, transposed brachiobasilic fistulas, and upper arm grafts. Clin J Am Soc Nephrol 2009; 4:86.
- Moossavi S, Tuttle AB, Vachharajani TJ, et al. Long-term outcomes of transposed basilic vein arteriovenous fistulae. Hemodial Int 2008; 12:80.
- RISK FACTORS
- MONITORING THE MATURE AVF
- Stenotic vascular lesions
- - Venous stenosis
- Sites of predilection
- - Swing points
- - Cephalic arch
- - Vein valves
- - Arterial stenosis
- Thrombosed fistula
- - Contraindications to attempted salvage
- - Salvage
- TREATMENT COMPLICATIONS
- SUMMARY AND RECOMMENDATIONS